Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genital Neoplasms, Female | 3 | 2020 | 38 | 0.740 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2020 | 37 | 0.700 |
Why?
|
| Uterine Cervical Neoplasms | 6 | 2005 | 300 | 0.290 |
Why?
|
| Gynecology | 2 | 2001 | 46 | 0.250 |
Why?
|
| Obstetrics | 2 | 2001 | 44 | 0.200 |
Why?
|
| Physician-Patient Relations | 2 | 2003 | 261 | 0.200 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 378 | 0.180 |
Why?
|
| History, 19th Century | 1 | 2020 | 95 | 0.180 |
Why?
|
| History, 21st Century | 1 | 2020 | 127 | 0.170 |
Why?
|
| History, 20th Century | 1 | 2020 | 248 | 0.170 |
Why?
|
| Endometriosis | 2 | 1998 | 56 | 0.160 |
Why?
|
| Rectovaginal Fistula | 1 | 1998 | 2 | 0.160 |
Why?
|
| Fibroma | 1 | 1998 | 20 | 0.160 |
Why?
|
| Uterine Prolapse | 1 | 1998 | 29 | 0.160 |
Why?
|
| Vaginal Smears | 5 | 2005 | 79 | 0.160 |
Why?
|
| Uterus | 1 | 1998 | 77 | 0.160 |
Why?
|
| Herniorrhaphy | 1 | 1998 | 38 | 0.150 |
Why?
|
| Cesarean Section | 1 | 1998 | 101 | 0.150 |
Why?
|
| Vaginal Neoplasms | 4 | 1991 | 21 | 0.150 |
Why?
|
| Papanicolaou Test | 3 | 2005 | 54 | 0.140 |
Why?
|
| Uterine Neoplasms | 5 | 1979 | 99 | 0.140 |
Why?
|
| Adenocarcinoma | 7 | 1979 | 475 | 0.130 |
Why?
|
| Uterine Cervical Dysplasia | 2 | 2005 | 44 | 0.120 |
Why?
|
| Female | 25 | 2020 | 38074 | 0.110 |
Why?
|
| Cervix Uteri | 2 | 1987 | 64 | 0.110 |
Why?
|
| Vulvar Neoplasms | 4 | 2004 | 24 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 7 | 2005 | 629 | 0.110 |
Why?
|
| Neoplasms | 1 | 2003 | 1667 | 0.100 |
Why?
|
| Humans | 25 | 2020 | 68618 | 0.080 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2005 | 46 | 0.070 |
Why?
|
| Insulin-Like Growth Factor II | 2 | 2005 | 52 | 0.070 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2005 | 5 | 0.060 |
Why?
|
| Fanconi Anemia | 1 | 2004 | 7 | 0.060 |
Why?
|
| Hysterectomy | 3 | 1979 | 64 | 0.060 |
Why?
|
| Medical Oncology | 1 | 1984 | 110 | 0.060 |
Why?
|
| Precancerous Conditions | 2 | 1976 | 74 | 0.060 |
Why?
|
| Papillomavirus Infections | 1 | 2005 | 194 | 0.050 |
Why?
|
| Adult | 13 | 2004 | 21403 | 0.050 |
Why?
|
| Pregnancy | 5 | 2001 | 2334 | 0.050 |
Why?
|
| Carcinoma | 3 | 1979 | 215 | 0.050 |
Why?
|
| Aged | 7 | 2003 | 14862 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2003 | 508 | 0.040 |
Why?
|
| Estradiol Congeners | 1 | 1979 | 3 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2003 | 4848 | 0.040 |
Why?
|
| Middle Aged | 7 | 2003 | 21147 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2001 | 445 | 0.030 |
Why?
|
| Cryosurgery | 1 | 1976 | 53 | 0.030 |
Why?
|
| Contraceptives, Postcoital | 1 | 1975 | 3 | 0.030 |
Why?
|
| Pregnancy, Tubal | 1 | 1975 | 5 | 0.030 |
Why?
|
| Diethylstilbestrol | 1 | 1975 | 45 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2003 | 2800 | 0.030 |
Why?
|
| Cytodiagnosis | 1 | 1973 | 20 | 0.030 |
Why?
|
| Pregnancy Complications | 3 | 1979 | 286 | 0.020 |
Why?
|
| Nevus | 1 | 1990 | 17 | 0.020 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1990 | 46 | 0.020 |
Why?
|
| Survival Analysis | 1 | 1991 | 714 | 0.020 |
Why?
|
| Ovarian Neoplasms | 3 | 1977 | 267 | 0.020 |
Why?
|
| Fallopian Tubes | 2 | 1977 | 11 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2004 | 1140 | 0.020 |
Why?
|
| Adolescent | 3 | 1987 | 8912 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2005 | 24 | 0.020 |
Why?
|
| Parity | 2 | 1977 | 71 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2005 | 122 | 0.010 |
Why?
|
| Costs and Cost Analysis | 2 | 1976 | 193 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2005 | 110 | 0.010 |
Why?
|
| Time Factors | 3 | 1979 | 4655 | 0.010 |
Why?
|
| Neutropenia | 1 | 2004 | 72 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1987 | 1342 | 0.010 |
Why?
|
| Interprofessional Relations | 1 | 1984 | 188 | 0.010 |
Why?
|
| Education, Medical | 1 | 1984 | 147 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 507 | 0.010 |
Why?
|
| Male | 2 | 2003 | 37321 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 1984 | 442 | 0.010 |
Why?
|
| Condylomata Acuminata | 2 | 1990 | 12 | 0.010 |
Why?
|
| Age Factors | 2 | 1979 | 1864 | 0.010 |
Why?
|
| Models, Biological | 1 | 2005 | 981 | 0.010 |
Why?
|
| Dysgerminoma | 2 | 1977 | 9 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 1991 | 7277 | 0.010 |
Why?
|
| Vesicovaginal Fistula | 1 | 1979 | 2 | 0.010 |
Why?
|
| Vaginal Fistula | 1 | 1979 | 3 | 0.010 |
Why?
|
| Ovary | 2 | 1977 | 99 | 0.010 |
Why?
|
| Ureteral Diseases | 1 | 1979 | 5 | 0.010 |
Why?
|
| Urinary Fistula | 1 | 1979 | 7 | 0.010 |
Why?
|
| Contraceptives, Oral | 1 | 1979 | 28 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 1753 | 0.010 |
Why?
|
| Rhabdomyosarcoma | 1 | 1979 | 36 | 0.010 |
Why?
|
| Postoperative Complications | 2 | 1979 | 1615 | 0.010 |
Why?
|
| Prospective Studies | 2 | 1977 | 3705 | 0.010 |
Why?
|
| Uterine Hemorrhage | 1 | 1977 | 16 | 0.010 |
Why?
|
| Body Weight | 1 | 1979 | 554 | 0.010 |
Why?
|
| Radium | 1 | 1977 | 12 | 0.010 |
Why?
|
| Placenta Diseases | 1 | 1976 | 5 | 0.010 |
Why?
|
| Colposcopy | 1 | 1976 | 20 | 0.010 |
Why?
|
| Estrogens | 1 | 1977 | 173 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1978 | 800 | 0.010 |
Why?
|
| Prognosis | 2 | 1978 | 2093 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 1976 | 306 | 0.010 |
Why?
|
| Pregnancy, Unwanted | 1 | 1975 | 7 | 0.010 |
Why?
|
| Embryo Implantation | 1 | 1975 | 17 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2004 | 1173 | 0.010 |
Why?
|
| Rupture | 1 | 1975 | 29 | 0.010 |
Why?
|
| Recurrence | 2 | 1975 | 948 | 0.010 |
Why?
|
| Castration | 1 | 1974 | 13 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 1976 | 340 | 0.010 |
Why?
|
| Curettage | 1 | 1973 | 7 | 0.010 |
Why?
|
| Endometrial Hyperplasia | 1 | 1973 | 4 | 0.010 |
Why?
|
| Laparotomy | 1 | 1973 | 65 | 0.010 |
Why?
|
| Dilatation | 1 | 1973 | 58 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2005 | 7029 | 0.010 |
Why?
|
| Melanoma | 2 | 1977 | 335 | 0.010 |
Why?
|
| United States | 1 | 1984 | 7367 | 0.010 |
Why?
|
| Granuloma Inguinale | 1 | 1971 | 1 | 0.010 |
Why?
|
| Leukoplakia | 1 | 1971 | 1 | 0.010 |
Why?
|
| Vulvar Lichen Sclerosus | 1 | 1971 | 2 | 0.010 |
Why?
|
| Pessaries | 1 | 1971 | 4 | 0.010 |
Why?
|
| Paget Disease, Extramammary | 1 | 1971 | 5 | 0.010 |
Why?
|
| Hemangiopericytoma | 1 | 1971 | 5 | 0.010 |
Why?
|
| Biopsy | 1 | 1973 | 540 | 0.010 |
Why?
|
| Nevus, Pigmented | 1 | 1971 | 30 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 1971 | 125 | 0.010 |
Why?
|
| Radiometry | 1 | 1971 | 64 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1971 | 47 | 0.010 |
Why?
|
| Leukoplakia, Oral | 1 | 1990 | 12 | 0.010 |
Why?
|
| Keratosis | 1 | 1990 | 17 | 0.010 |
Why?
|
| Obesity | 1 | 1977 | 1076 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1971 | 375 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1971 | 3259 | 0.000 |
Why?
|
| Child | 1 | 1971 | 6405 | 0.000 |
Why?
|
| Cystadenoma | 1 | 1977 | 10 | 0.000 |
Why?
|
| Carcinoma in Situ | 1 | 1977 | 47 | 0.000 |
Why?
|
| Sarcoma | 1 | 1977 | 70 | 0.000 |
Why?
|
| Sex Chromatin | 1 | 1976 | 1 | 0.000 |
Why?
|
| Neoplasm Invasiveness | 1 | 1978 | 369 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1975 | 219 | 0.000 |
Why?
|
| Pancreatic Neoplasms | 1 | 1976 | 332 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1976 | 2455 | 0.000 |
Why?
|